PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

Ann: Clarification of recent analyst report on Patent Protection, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,362 Posts.
    lightbulb Created with Sketch. 6909
    Yes agreed, good that PAR are defending themselves. Morgan's are silly revising their entire forecast based on one operational point which is flawed! What, is Morgans going to revise their forecast at every operational change (both negative AND positive?), clearly not independent when it comes to us..




    https://hotcopper.com.au/data/attachments/4155/4155932-98fdc7b6fc12bb32a7015745644a0f9b.jpg



    https://hotcopper.com.au/data/attachments/4155/4155935-aed15c75fa3d6d32935c3f5216fc9ea9.jpg
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.